Ryan Paul, MBChB, PhD, a senior lecturer at the University of Waikato in New Zealand, discusses updates for the care of patients with type 2 diabetes. Dr Paul, an Executive Member of the New Zealand Society for the Study of Diabetes, recently led the development of type 2 diabetes management guidance in New Zealand. Dr Paul discusses the appropriate use of SGLT2 inhibitors and GLP1 receptor agonists.